The latest update is out from Essex Bio-Technology ( (HK:1061) ).
Essex Bio-Technology Limited has announced proposed amendments to its Articles of Association to align with the latest regulatory requirements, including the expanded paperless listing regime and changes to the Listing Rules regarding treasury shares. These amendments are aimed at ensuring compliance with recent regulatory updates and will be subject to shareholder approval at the upcoming annual general meeting.
More about Essex Bio-Technology
Essex Bio-Technology Limited is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company focuses on developing and marketing biopharmaceutical products, with a particular emphasis on ophthalmology and dermatology treatments.
YTD Price Performance: 32.65%
Average Trading Volume: 778,298
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.05B
For detailed information about 1061 stock, go to TipRanks’ Stock Analysis page.